Thymosin Alpha-1 Has no Beneficial Effect on Restoring CD4+ and CD8+ T Lymphocyte Counts in COVID-19 Patients
Immunology
[키워드] age
baseline CD4
benefit
cancers
CD4
CD4 counts
CD4+
CD8
CD8+
CD8+ T cell
Clinical Center
conducted
count
COVID-19
COVID-19 patient
COVID-19 patients
Critically ill
Effect
Efficacy
evaluate
homeostasis
hypertension
immune response
immune system
Infection
investigated
laboratory characteristics
Linear regression analysis
longitudinal change
males
management
multivariate
no significant difference
no statistical difference
observé
Older
Patient
patients
phenotype
public health
reduction
Restoring
Retrospective study
severity
Shanghai
significantly
subset
T lymphocyte
the median
the patient
therapy
thymosin alpha 1
thymosin alpha-1
treated
two group
upper respiratory tract
virus
virus clearance
[DOI] 10.3389/fimmu.2021.568789 PMC 바로가기 [Article Type] Immunology
[DOI] 10.3389/fimmu.2021.568789 PMC 바로가기 [Article Type] Immunology